https://news.medxy.ai/zh/cd276-chemotherapy-resistance/Medxy AIzh2026-04-29T20:03:23-07:00CD276 被确定为晚期胰腺癌化疗耐药的关键驱动因素 https://news.medxy.ai/ja/cd276-and-pancreatic-cancer/Medxy AIja2026-04-29T20:02:40-07:00CD276が進行膵癌の化学療法耐性の主要なドライバーとして特定 https://news.medxy.ai/vi/cd276-key-factor-chemoresistance/Medxy AIvi2026-04-29T20:01:47-07:00CD276 Được Xác Định Là Yếu Tố Quyết Định Sự Kháng Hóa Chất trong U Tụy Tiến Triển https://news.medxy.ai/cd276-chemoresistance-pancreatic-cancer/Medxy AIen2026-04-29T19:59:09-07:00CD276 Identified as Key Driver of Chemoresistance in Advanced Pancreatic Cancer https://news.medxy.ai/intracranial-hemorrhage-outcomes/Medxy AIen2026-04-29T19:39:09-07:00Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Insights from the TEMPO-2 Trial https://news.medxy.ai/zh/zuranolone-efficacy-epilepsy/Medxy AIzh2026-04-29T19:33:16-07:00左乙拉西坦在药物难治性局灶性癫痫中的卓越疗效：真实世界证据 https://news.medxy.ai/ja/senobamate-focal-epilepsy-efficacy/Medxy AIja2026-04-29T19:32:10-07:00難治性局灶性癲癇に対するセノバマートの優れた効果：実世界の証拠 https://news.medxy.ai/vi/superior-efficacy-cenobamate/Medxy AIvi2026-04-29T19:31:33-07:00Hiệu quả vượt trội của Cenobamate trong động kinh cục bộ kháng thuốc: Bằng chứng thực tế https://news.medxy.ai/superior-efficacy-cenobamate-epilepsy/Medxy AIen2026-04-29T19:29:33-07:00Superior Efficacy of Cenobamate in Drug-Resistant Focal Epilepsy: Real-World Evidence https://news.medxy.ai/zh/microplastics-thyroid-autoimmunity/Medxy AIzh2026-04-29T13:49:29-07:00人类甲状腺中的微塑料：自身免疫性甲状腺炎的潜在触发因素 https://news.medxy.ai/ja/microplastics-thyroid-autoimmunity/Medxy AIja2026-04-29T13:48:27-07:00人間の甲状腺におけるマイクロプラスチック：自己免疫性甲状腺炎の潜在的な引き金 https://news.medxy.ai/vi/microplastics-thyroid-autoimmunity/Medxy AIvi2026-04-29T13:47:25-07:00Nhựa vi nhựa trong tuyến giáp: Một yếu tố kích hoạt tiềm năng cho viêm tuyến giáp tự miễn https://news.medxy.ai/microplastics-autoimmune-thyroiditis/Medxy AIen2026-04-29T13:44:45-07:00Microplastics in Human Thyroid: A Potential Trigger for Autoimmune Thyroiditis https://news.medxy.ai/zh/race-immigration-mental-health/Medxy AIzh2026-04-29T13:43:24-07:00种族、移民与精神健康：2型糖尿病差异中的独立风险因素持续存在 https://news.medxy.ai/ja/migrants-mental-health/Medxy AIja2026-04-29T13:42:30-07:00民族、移民と精神健康：2型糖尿病の不平等性に影響を及ぼす独立したリスク要因 https://news.medxy.ai/vi/ethnicity-migration-mental-health/Medxy AIvi2026-04-29T13:41:11-07:00Dân tộc, Di cư và Sức khỏe Tâm thần: Các Yếu tố Nguy cơ Độc lập vẫn Tồn tại trong Sự Khác biệt của Bệnh Tiểu đường Loại 2 https://news.medxy.ai/ethnicity-migration-mental-health/Medxy AIen2026-04-29T13:38:59-07:00Ethnicity, Migration, and Mental Health: Independent Risk Factors Persist in Type 2 Diabetes Disparities https://news.medxy.ai/zh/ai-thyroid-discovery-insights/Medxy AIzh2026-04-29T13:15:25-07:00人工智能驱动的偶然甲状腺发现见解：流行率、临床影响及过度诊断困境 https://news.medxy.ai/ja/ai-thyroid-findings-insights/Medxy AIja2026-04-29T13:14:59-07:00偶発性甲状腺所見に関するAI駆動の洞察：頻度、臨床的影響、および過剰診断のジレンマ https://news.medxy.ai/vi/ai-thyroid-findings/Medxy AIvi2026-04-29T13:14:25-07:00Những Nhận Định Được Hỗ Trợ bởi AI về Các Phát Hiện Tuyến Giáp Ngẫu Nhiên: Tần Suất, Tác Động Lâm Sàng và Vấn Đề Chẩn Đoán Quá mức https://news.medxy.ai/ai-thyroid-findings/Medxy AIen2026-04-29T13:11:54-07:00AI-Driven Insights into Incidental Thyroid Findings: Prevalence, Clinical Impact, and the Overdiagnosis Dilemma https://news.medxy.ai/zh/intermittent-physical-activity-diabetes-prevention/Medxy AIzh2026-04-29T13:10:32-07:00间歇性生活方式体力活动：2型糖尿病预防的有前景策略 https://news.medxy.ai/ja/intermittent-lifestyle-activities/Medxy AIja2026-04-29T13:10:02-07:00間欠的な生活活動：2型糖尿病予防の有望な戦略 https://news.medxy.ai/vi/repetitive-physical-activity-diabetes-prevention/Medxy AIvi2026-04-29T13:09:15-07:00Hoạt động thể chất lặp đi lặp lại trong lối sống: Một chiến lược hứa hẹn để phòng ngừa bệnh đái tháo đường tuýp 2 https://news.medxy.ai/intermittent-physical-activity/Medxy AIen2026-04-29T13:07:29-07:00Intermittent Lifestyle Physical Activity: A Promising Strategy for Type 2 Diabetes Prevention https://news.medxy.ai/zh/continuous-glucose-monitoring-2-diabetes/Medxy AIzh2026-04-29T12:31:35-07:00实时连续葡萄糖监测在基础胰岛素加现代疗法治疗2型糖尿病中的血糖控制优于自我血糖监测 https://news.medxy.ai/ja/real-time-cgm-better-smbg/Medxy AIja2026-04-29T12:30:53-07:00リアルタイムCGMがSMBGを上回り、基礎インスリンと現代療法を使用する2型糖尿病の血糖制御に優れた効果 https://news.medxy.ai/vi/continuous-glucose-monitoring-diabetes/Medxy AIvi2026-04-29T12:28:47-07:00Đo glucose liên tục theo thời gian thực hiệu quả hơn so với SMBG trong kiểm soát đường huyết cho bệnh tiểu đường tuýp 2 điều trị bằng insulin cơ bản và các liệu pháp hiện đại https://news.medxy.ai/real-time-cgm-vs-smbg/Medxy AIen2026-04-29T12:24:43-07:00Real-Time CGM Outperforms SMBG in Glycemic Control for Type 2 Diabetes on Basal Insulin Plus Modern Therapies https://news.medxy.ai/zh/hiv-heart-failure-risk/Medxy AIzh2026-04-29T12:03:50-07:00HIV 感染者心力衰竭风险升高：来自 REPRIEVE 试验的见解 https://news.medxy.ai/ja/hiv-patients-heart-failure-risk/Medxy AIja2026-04-29T12:03:12-07:00HIV患者中心力衰竭风险升高：来自REPRIEVE试验的见解 https://news.medxy.ai/vi/heart-failure-risk-hiv/Medxy AIvi2026-04-29T12:02:30-07:00Nguy cơ suy tim tăng cao ở người mắc HIV: Những hiểu biết từ thử nghiệm REPRIEVE https://news.medxy.ai/elevated-hf-risk-hiv/Medxy AIen2026-04-29T12:00:02-07:00Elevated Heart Failure Risk in People With HIV: Insights from the REPRIEVE Trial https://news.medxy.ai/zh/exercises-in-cpvt-diagnosis/Medxy AIzh2026-04-29T11:51:35-07:00突发性运动试验在CPVT诊断和管理中优于传统的布鲁斯方案 https://news.medxy.ai/ja/burst-exercise-test-cpvt/Medxy AIja2026-04-29T11:50:24-07:00バースト運動負荷試験、伝統的なブルースプロトコルを上回るCPVT診断と管理 https://news.medxy.ai/vi/burst-test-vs-bruce/Medxy AIvi2026-04-29T11:49:34-07:00Bài kiểm tra vận động Burst hiệu quả hơn giao thức truyền thống Bruce trong chẩn đoán và quản lý CPVT https://news.medxy.ai/burst-exercise-testing-cpvt/Medxy AIen2026-04-29T11:46:34-07:00Burst Exercise Testing Outperforms Traditional Bruce Protocol in CPVT Diagnosis and Management https://news.medxy.ai/zh/lung-health-and-longevity/Medxy AIzh2026-04-29T10:26:34-07:00中年心肺功能与延长健康寿命和减少老年多病相关 https://news.medxy.ai/ja/midlife-cardiopulmonary-health/Medxy AIja2026-04-29T10:26:00-07:00中年心肺適応性と健康寿命の延長、高齢期の多病性減少の関連 https://news.medxy.ai/vi/cardiopulmonary-endurance-aging/Medxy AIvi2026-04-29T10:25:20-07:00Khả năng chịu đựng tim phổi ở giữa cuộc đời liên quan đến thời gian khỏe mạnh kéo dài và giảm đa bệnh trong quá trình lão hóa https://news.medxy.ai/midlife-fitness-healthspan/Medxy AIen2026-04-29T10:23:03-07:00Midlife Cardiorespiratory Fitness Linked to Extended Healthspan and Reduced Multimorbidity in Aging https://news.medxy.ai/zh/cardiovascular-kidney-metabolism-risk/Medxy AIzh2026-04-29T00:28:06-07:00探索心血管-肾脏-代谢综合征与老年人心力衰竭风险之间的联系 https://news.medxy.ai/ja/cardiovascular-kidney-metabolic-syndrome/Medxy AIja2026-04-29T00:27:27-07:00高齢者における心血管-腎-代謝症候群と心不全リスクの関連性の解明 https://news.medxy.ai/vi/cardiac-renal-metabolic-syndrome/Medxy AIvi2026-04-29T00:26:14-07:00Khám phá mối liên hệ giữa hội chứng tim mạch-thận-chuyển hóa và nguy cơ suy tim ở người cao tuổi https://news.medxy.ai/cardiovascular-kidney-syndrome/Medxy AIen2026-04-29T00:23:09-07:00Exploring the Link Between Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure Risk in Older Adults https://news.medxy.ai/zh/high-p-tau217-cognition-decline/Medxy AIzh2026-04-28T19:52:36-07:00女性P-Tau217水平升高及认知功能下降加速：对临床前期阿尔茨海默病的影响 https://news.medxy.ai/ja/p-tau217-levels-cognition-decline/Medxy AIja2026-04-28T19:52:01-07:00女性のP-Tau217レベル上昇と認知機能の急速な低下：前臨床アルツハイマー病への影響 https://news.medxy.ai/vi/p-tau217-levels-alzheimers/Medxy AIvi2026-04-28T19:50:51-07:00Mức độ P-Tau217 tăng cao ở phụ nữ và suy giảm nhận thức nhanh hơn: Ý nghĩa đối với bệnh Alzheimer tiền lâm sàng https://news.medxy.ai/womens-elevated-p-tau217/Medxy AIen2026-04-28T19:48:23-07:00Women’s Elevated P-Tau217 Levels and Faster Cognitive Decline: Implications for Preclinical Alzheimer’s Disease https://news.medxy.ai/zh/p-tau217-tau-gender-differences/Medxy AIzh2026-04-28T16:36:46-07:00P-τ217和tau聚集的性别差异：对临床前期阿尔茨海默病的影响 https://news.medxy.ai/ja/p-tau217-sex-differences/Medxy AIja2026-04-28T16:35:48-07:00性差によるP-Tau217とタウ凝集の違い：前臨床アルツハイマー病への影響 https://news.medxy.ai/vi/gender-differences-p-tau217/Medxy AIvi2026-04-28T16:34:44-07:00Sự khác biệt theo giới tính trong P-Tau217 và sự tích tụ của Tau: Ý nghĩa đối với bệnh Alzheimer tiền lâm sàng https://news.medxy.ai/sex-specific-tau-differences/Medxy AIen2026-04-28T16:32:29-07:00Sex-Specific Differences in P-Tau217 and Tau Aggregation: Implications for Preclinical Alzheimer’s Disease https://news.medxy.ai/zh/amlenetug-potential-in-msa/Medxy AIzh2026-04-28T16:31:31-07:00Amlenetug 在减缓多系统萎缩症进展方面显示出潜力，尽管 II 期试验未达到主要终点 https://news.medxy.ai/ja/amurenutogu-msa-progress/Medxy AIja2026-04-28T16:30:51-07:00アムレヌトグ、一次エンドポイントには未達もMSAの進行を遅らせる可能性を示す https://news.medxy.ai/vi/amlentug-msa-potential/Medxy AIvi2026-04-28T16:30:09-07:00Amlenetug có tiềm năng làm chậm tiến triển của MSA mặc dù thử nghiệm giai đoạn 2 không đạt tiêu chí chính https://news.medxy.ai/amlenetug-msa-progression/Medxy AIen2026-04-28T16:27:27-07:00Amlenetug Shows Potential in Slowing MSA Progression Despite Phase 2 Trial Missing Primary Endpoint https://news.medxy.ai/zh/postmenopausal-thyroid-cancer-tsh/Medxy AIzh2026-04-28T16:21:55-07:00绝经后甲状腺癌患者长期抑制TSH与更差的心血管和生活质量结果相关 https://news.medxy.ai/ja/tsh-suppression-postmenopause/Medxy AIja2026-04-28T16:21:08-07:00閉経後の甲状腺がん患者における長期的なTSH抑制が心血管疾患と生活の質の悪化と関連 https://news.medxy.ai/vi/tsh-suppression-therapy-thyroid-cancer/Medxy AIvi2026-04-28T16:18:04-07:00Liệu pháp ức chế TSH kéo dài ở bệnh nhân ung thư tuyến giáp sau mãn kinh liên quan đến kết quả tim mạch và chất lượng cuộc sống xấu hơn https://news.medxy.ai/tsh-suppression-heart-health/Medxy AIen2026-04-28T16:15:19-07:00Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes https://news.medxy.ai/zh/exercise-break-improves-diabetes/Medxy AIzh2026-04-28T16:05:55-07:00运动小憩改善2型糖尿病患者的血糖控制：一项真实世界的随机交叉研究 https://news.medxy.ai/ja/exercise-snacks-improve-blood-sugar/Medxy AIja2026-04-28T16:04:46-07:00運動スナックが2型糖尿病の血糖コントロールを改善：実世界でのランダム化クロスオーバー研究 https://news.medxy.ai/vi/short-exercise-blood-glucose-diabetes/Medxy AIvi2026-04-28T16:02:57-07:00Bài tập ngắn cải thiện kiểm soát đường huyết trong đái tháo đường tuýp 2: Một nghiên cứu ngẫu nhiên qua trung gian thực tế https://news.medxy.ai/exercise-snacks-glycemic-control/Medxy AIen2026-04-28T16:00:12-07:00Exercise Snacks Improve Glycemic Control in Type 2 Diabetes: A Real-World Randomized Crossover Study https://news.medxy.ai/endocrine-profile-bbs/Medxy AIen2026-04-28T13:39:20-07:00Endocrine Profile in Pediatric Bardet-Biedl Syndrome: Insights from a Large Multidisciplinary Cohort https://news.medxy.ai/zh/circulatory-support-upgrade/Medxy AIzh2026-04-28T12:29:36-07:00心源性休克中的循环支持升级：结果和成功预测因素 https://news.medxy.ai/ja/circulatory-support-esc-escalation/Medxy AIja2026-04-28T12:28:49-07:00心原性ショックにおける循環サポートのエスカレーション：結果と成功の予測因子 https://news.medxy.ai/vi/enhanced-circulation-support-in-cardiac-shock/Medxy AIvi2026-04-28T12:27:25-07:00Hỗ trợ tuần hoàn tăng cường trong sốc tim: Kết quả và các yếu tố dự đoán thành công https://news.medxy.ai/circulatory-support-cardiogenic-shock/Medxy AIen2026-04-28T12:24:54-07:00Circulatory Support Escalation in Cardiogenic Shock: Outcomes and Predictors of Success https://news.medxy.ai/zh/rbm20-truncations-in-dilated-cardiomyopathy/Medxy AIzh2026-04-28T12:18:30-07:00扩张型心肌病中RBM20截短变异：与错义变异相比，其外显率降低且表型较轻 https://news.medxy.ai/ja/rbm20-deletion-in-dilated-cardiomyopathy/Medxy AIja2026-04-28T12:17:37-07:00拡張型心筋症におけるRBM20の欠失変異：ミスセンス変異と比較して低浸透性と軽度な症状 https://news.medxy.ai/vi/rbm20-short-variant-hypertrophic-cardiomyopathy/Medxy AIvi2026-04-28T12:16:32-07:00Biến thể cắt ngắn RBM20 trong bệnh cơ tim phì đại: Tỷ lệ mắc bệnh thấp hơn và biểu hiện lâm sàng nhẹ hơn so với biến thể thay thế missense https://news.medxy.ai/rbm20-truncating-variants/Medxy AIen2026-04-28T12:12:30-07:00RBM20 Truncating Variants in Dilated Cardiomyopathy: Reduced Penetrance and Milder Phenotype Compared to Missense Variants https://news.medxy.ai/fibrin-clot-lysis-time-bleeding-risk/Medxy AIen2026-04-28T12:07:55-07:00Pre-Treatment Fibrin Clot Lysis Time Predicts Bleeding Risk in Atrial Fibrillation Patients on Oral Anticoagulants https://news.medxy.ai/zh/global-heart-failure-differences/Medxy AIzh2026-04-28T11:54:20-07:00全球心力衰竭差异：不同收入水平和地区的发病率与死亡率 https://news.medxy.ai/ja/heart-failure-inequality/Medxy AIja2026-04-28T11:52:44-07:00心不全の世界的不均衡：所得水準と地域別の発症率と死亡率 https://news.medxy.ai/vi/global-inequality-heart-failure/Medxy AIvi2026-04-28T11:51:38-07:00Bất bình đẳng toàn cầu trong suy tim: Tỷ lệ mắc mới và tử vong theo mức thu nhập và khu vực https://news.medxy.ai/global-heart-failure-disparities/Medxy AIen2026-04-28T11:48:32-07:00Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions https://news.medxy.ai/zh/praetorian-dft-sicd-validation/Medxy AIzh2026-04-28T11:46:20-07:00PRAETORIAN-DFT试验验证了S-ICD植入中省略除颤测试的有效性 https://news.medxy.ai/ja/praetorian-dft-test/Medxy AIja2026-04-28T11:45:15-07:00PRAETORIAN-DFT試験、S-ICD植込みにおける除細動テストの省略を検証 https://news.medxy.ai/vi/praetorian-dft-sicd/Medxy AIvi2026-04-28T11:43:45-07:00Thử nghiệm PRAETORIAN-DFT xác nhận việc bỏ qua kiểm tra khử rung trong cấy ghép S-ICD https://news.medxy.ai/praetorian-dft-trial/Medxy AIen2026-04-28T11:40:47-07:00PRAETORIAN-DFT Trial Validates Omission of Defibrillation Testing in S-ICD Implantation https://news.medxy.ai/zh/palliative-care-gap-cancer-youth/Medxy AIzh2026-04-28T10:00:42-07:00解决接受医疗援助死亡的青少年和年轻成人癌症患者的姑息治疗缺口 https://news.medxy.ai/ja/palliative-care-gaps-adolescents/Medxy AIja2026-04-28T09:59:35-07:00医師の指示による死に際する緩和ケアのギャップ：思春期および若年成人がん患者の対応 https://news.medxy.ai/vi/addressing-palliative-care-gaps/Medxy AIvi2026-04-28T09:58:37-07:00Đối phó với khoảng cách chăm sóc giảm nhẹ trong bệnh nhân ung thư thanh thiếu niên và người trẻ tuổi nhận hỗ trợ y tế trong việc chết https://news.medxy.ai/palliative-care-gap-adolescents/Medxy AIen2026-04-28T09:54:47-07:00Addressing the Palliative Care Gap in Adolescent and Young Adult Cancer Patients Receiving Medical Assistance in Dying